Consecutive patients with first presentation of external anogenital warts had the location, duration at presentation, number of warts and wart area, age, smoking and sun bed use, and presence of coexistent sexually transmitted infections (STIs) recorded. The number of treatment episodes, and number of weeks, to clear the warts were documented. Number of warts and [...]
To evaluate the clinical efficacy of a 0.15% and a 0.3% cream formulation of podophyllotoxin in comparison with the 0.5% solution in the treatment of condylomata acuminata and to compare the treatment modalities regarding side effects. DESIGN–The study was designed as an open randomised trial. Ninety male patients with signs of penile HPV infection, with [...]
2010-03-13 |
genital warts |
Human papillomaviruses (HPV) cause benign and malignant hyperproliferative disease. A woman infected with HPV 16 (a high risk HPV)
has a 200-fold increased risk for the development of cervical cancer while one infected with HPV 6 (a low risk HPV) has a 10-fold increased risk. Notably, HPV 6 is the causative agent of the most prevalent [...]
2010-03-09 |
genital warts |
The human papillomavirus (HPV) is a significant etiologic agent in lower female genital tract neoplasia. Novel interactions with other co-carcinogens and/or immuno-deficiency lead to tumorigenesis and cancer progression. However, both the lack of adequate animal models and prospective clinical trials are impediments to the development of effective anti-HPV therapies and prevent a thorough understanding of [...]
2010-03-09 |
genital warts |
Human immunodeficiency virus (HIV) has infected over 33 million people worldwide leading to immune suppression from the selective depletion of CD4+ T cells. This lack of immunity results in numerous opportunistic infections with over 50% of the HIV-infected individuals developing pathology involving the oral cavity. Among the pathogens responsible for oral disease in HIV+ patients [...]
2010-03-09 |
genital warts |
Genital human papillomavirus (HPV) infections represent the most common viral sexually transmitted disease in the United States. These functions cause conditions that include anogenital warts and cervical dysplasias. These diseases can spontaneously regress but the immunologic mechanisms that contribute to the regression are poorly characterized. The experiments in animal models strongly suggest that papillomavirus-associated diseases [...]
2010-03-09 |
genital warts |
The human papillomaviruses (HPVs) are associated with specific human cancers, most notably human cervical cancer. More than 70 different HPVs have now been described and approximately 25 of these are associated with lesions of the anogenital tract. These anogenital associated HPVs can be further subdivided into two groups on the basis of the clinical lesions [...]
2010-03-09 |
genital warts |
Human papillomaviruses (primarily HPV 16 and 18) play a central role in the development of in situ and invasive cervical cancer. Based on this observation and the well-recognized shortcomings of Pap smears, several groups have examined the use of HPV DNA testing as an adjunct to cytologic screening and found it to be cost effective. [...]
2010-03-09 |
genital warts |
The incidence of condylomata acuminata in children seems to be increasing, paralleling a rising incidence reported in adults. This article reviews condylomata acuminata in children. The etiologic agent is the human papillomavirus (HPV), which causes soft, clustered, papillomatous growths of various sizes and shapes seen on moist mucosal surfaces, most frequently around the genital and [...]
2010-03-07 |
genital warts |
Human Papilloma Virus (HPV) is the most common sexually transmitteddisease in the United States. It is also harder to understand thanother STDs. It is actually a group of common viruses which cause wartson different parts of the body. There are particular strains of thatcause genital warts and [...]